These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22284354)

  • 1. Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.
    Burris TP; Busby SA; Griffin PR
    Chem Biol; 2012 Jan; 19(1):51-9. PubMed ID: 22284354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.
    Kiss M; Czimmerer Z; Nagy L
    J Allergy Clin Immunol; 2013 Aug; 132(2):264-86. PubMed ID: 23905916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptors as drug targets for metabolic disease.
    Schulman IG
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1307-15. PubMed ID: 20655343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural products as modulators of retinoic acid receptor-related orphan receptors (RORs).
    Ladurner A; Schwarz PF; Dirsch VM
    Nat Prod Rep; 2021 Apr; 38(4):757-781. PubMed ID: 33118578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver receptor homolog-1: structures, related diseases, and drug discovery.
    Wu T; Lu ZF; Yu HN; Wu XS; Liu Y; Xu Y
    Acta Pharmacol Sin; 2024 Aug; 45(8):1571-1581. PubMed ID: 38632319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARs and other nuclear receptors in inflammation.
    Rizzo G; Fiorucci S
    Curr Opin Pharmacol; 2006 Aug; 6(4):421-7. PubMed ID: 16777482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photohormones Enable Optical Control of the Peroxisome Proliferator-Activated Receptor γ (PPARγ).
    Hinnah K; Willems S; Morstein J; Heering J; Hartrampf FWW; Broichhagen J; Leippe P; Merk D; Trauner D
    J Med Chem; 2020 Oct; 63(19):10908-10920. PubMed ID: 32886507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages.
    Szanto A; Benko S; Szatmari I; Balint BL; Furtos I; Rühl R; Molnar S; Csiba L; Garuti R; Calandra S; Larsson H; Diczfalusy U; Nagy L
    Mol Cell Biol; 2004 Sep; 24(18):8154-66. PubMed ID: 15340076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptors as pharmaceutical targets: rise of FXR and rebirth of PPAR?
    Merk D; Schubert-Zsilavecz M
    Future Med Chem; 2012 Apr; 4(5):587-8. PubMed ID: 22458677
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological importance of orphan nuclear receptors].
    Sima M; Slanar O
    Cesk Fysiol; 2014; 63(1):19-24. PubMed ID: 24968536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting PPARγ as a target for the treatment of metabolic disorders.
    Choi SS; Park J; Choi JH
    BMB Rep; 2014 Nov; 47(11):599-608. PubMed ID: 25154720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells.
    Papi A; Guarnieri T; Storci G; Santini D; Ceccarelli C; Taffurelli M; De Carolis S; Avenia N; Sanguinetti A; Sidoni A; Orlandi M; Bonafé M
    Cell Death Differ; 2012 Jul; 19(7):1208-19. PubMed ID: 22261616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor.
    Luo Y; Liang CP; Tall AR
    J Biol Chem; 2001 Jul; 276(27):24767-73. PubMed ID: 11331284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors and acute lung injury.
    Cuzzocrea S
    Curr Opin Pharmacol; 2006 Jun; 6(3):263-70. PubMed ID: 16580256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure.
    Thiemermann C
    Br J Pharmacol; 2004 Jul; 142(6):1049-51. PubMed ID: 15303252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear receptors PPAR as a drug target in metabolic disorders].
    Stolarczyk M; Gutman W; Derlacz RA
    Postepy Biochem; 2011; 57(2):207-14. PubMed ID: 21913422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor {gamma} stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway.
    Yue L; Mazzone T
    J Biol Chem; 2009 Apr; 284(16):10453-61. PubMed ID: 19218241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptors in disease: thyroid receptor beta, peroxisome-proliferator-activated receptor gamma and orphan receptors.
    Gurnell M; Chatterjee VK
    Essays Biochem; 2004; 40():169-89. PubMed ID: 15242346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear hormone receptor PPARγ as a therapeutic target in major diseases.
    Schmidt MV; Brüne B; von Knethen A
    ScientificWorldJournal; 2010 Nov; 10():2181-97. PubMed ID: 21057731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
    Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
    J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.